Table 2. Markers of inflammation and soreness in response to eccentric strength exercise. Data are means (±SE) or counts (%).

	DHA (n = 14)	Placebo (n = 13)	Between-group p-value
Soreness rating, palpated, cm Baseline 48h follow- up Change Within group P value	.0 (.0) 4.3 (.4) 4.3 (.4) <.0001	.0 (.0) 5.6 (.5) 5.6 (.5) <.0001	.02
Soreness rating, full elbow extension, cm Baseline 48h follow- up Change Within group P value	.0 (.0) 5.1 (.5) 5.1 (.5) <.0001	.1 (.1) 5.5 (.6) 5.4 (.5) <.0001	.62
Inability to fully extend elbow at 48h follow-up, count (%)	4 (29%)	11 (85%)	.006
Passive elbow joint angle, degrees of extension Baseline 48h follow-up Change Within group P value	167(2) 155(3) - 12(2) <.0001	166(1) 155(2) - 11(2) .0004	.78
Arm circumference, cm Baseline 48h follow- up Change Within group P value	27.2 (1.1) 27.6 (1.1) .4 (.1) .0002	28.6 (1.5) 29.1 (1.5) .5 (.1) <.0001	.75
Skin temperature, ËšC Baseline 48h follow- up Change Within group P value	31.0 (.2) 30.7 (.0.2) -.3 (.2) .16	30.7 (.3) 30.5 (.4) -.2 (.2) .34	.55
C-Reactive Protein (salivary), log pg/mL Baseline 48h follow-up Change Within group P value	7.67 (.21) 7.71 (.21) .03 (.06) .55	8.50 (.36) 8.58 (.36) .07 (.09) .46	.74

Within-group p-values are from paired t-tests comparing baseline and 48h follow-up values. Between-group p-values are from analysis of covariance tests in which change-scores were the dependent variables, study group (DHA vs. placebo) was the independent variable, and age, BMI, and baseline values for the outcome were included as covariates. Between-group comparisons of frequencies (percentages) were performed with a Fisher’s exact test. Soreness ratings were collected by using a 10 cm visual analog scale.